Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DBPC Peanut SLIT
NCT00597727Phase 2Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Jan 2008
- Primary completion
- Mar 2016
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of peanut allergen extract (UNC Chapel Hill) in peanut allergy (3 arms), sponsored by University of North Carolina at Chapel Hill. Primary endpoint: Percentage of Subjects Who Can Tolerate the Peanut Oral Food Challenge After 12 Months of Peanut SLIT Dosing. Started Jan 2008; status: completed.
02
Drugs
peanut allergen extract (UNC Chapel Hill)
03
Conditions
peanut allergy
Beyond the preview
Go deeper on NCT00597727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00597727.